721 related articles for article (PubMed ID: 12062610)
1. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
[TBL] [Abstract][Full Text] [Related]
4. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study.
Ciseł B; Pietrzak L; Michalski W; Wyrwicz L; Rutkowski A; Kosakowska E; Cencelewicz A; Spałek M; Polkowski W; Jankiewicz M; Styliński R; Bębenek M; Kapturkiewicz B; Maciejczyk A; Sadowski J; Zygulska J; Zegarski W; Jankowski M; Las-Jankowska M; Toczko Z; Żelazowska-Omiotek U; Kępka L; Socha J; Wasilewska-Tesluk E; Markiewicz W; Kładny J; Majewski A; Kapuściński W; Suwiński R; Bujko K;
Ann Oncol; 2019 Aug; 30(8):1298-1303. PubMed ID: 31192355
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer. Long-term outcome analysis.
Calvo FA; Sole CV; Serrano J; Del Valle E; Rodriguez M; Muñoz-Calero A; García-Sabrido JL; Garcia-Alfonso P; Peligros I; Alvarez E
Strahlenther Onkol; 2014 Feb; 190(2):149-57. PubMed ID: 24306062
[TBL] [Abstract][Full Text] [Related]
6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
8. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
9. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
[TBL] [Abstract][Full Text] [Related]
10. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT).
Sainato A; Cernusco Luna Nunzia V; Valentini V; De Paoli A; Maurizi ER; Lupattelli M; Aristei C; Vidali C; Conti M; Galardi A; Ponticelli P; Friso ML; Iannone T; Osti FM; Manfredi B; Coppola M; Orlandini C; Cionini L
Radiother Oncol; 2014 Nov; 113(2):223-9. PubMed ID: 25454175
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.
Picardi V; Macchia G; Guido A; Giaccherini L; Deodato F; Farioli A; Cilla S; Compagnone G; Ardizzoni A; Cuicchi D; Gambacorta MA; Cellini F; Frezza G; Poggioli G; Valentini V; Fuccio L; Morganti AG
Clin Colorectal Cancer; 2017 Mar; 16(1):16-22. PubMed ID: 27435759
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim E; Kim K; Oh H; Han SW; Kim TY; Jung SY; Park KJ; Kang GH; Chie EK
J BUON; 2019; 24(2):470-478. PubMed ID: 31127993
[TBL] [Abstract][Full Text] [Related]
14. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.
Bujko K; Wyrwicz L; Rutkowski A; Malinowska M; Pietrzak L; Kryński J; Michalski W; Olędzki J; Kuśnierz J; Zając L; Bednarczyk M; Szczepkowski M; Tarnowski W; Kosakowska E; Zwoliński J; Winiarek M; Wiśniowska K; Partycki M; Bęczkowska K; Polkowski W; Styliński R; Wierzbicki R; Bury P; Jankiewicz M; Paprota K; Lewicka M; Ciseł B; Skórzewska M; Mielko J; Bębenek M; Maciejczyk A; Kapturkiewicz B; Dybko A; Hajac Ł; Wojnar A; Leśniak T; Zygulska J; Jantner D; Chudyba E; Zegarski W; Las-Jankowska M; Jankowski M; Kołodziejski L; Radkowski A; Żelazowska-Omiotek U; Czeremszyńska B; Kępka L; Kolb-Sielecki J; Toczko Z; Fedorowicz Z; Dziki A; Danek A; Nawrocki G; Sopyło R; Markiewicz W; Kędzierawski P; Wydmański J;
Ann Oncol; 2016 May; 27(5):834-42. PubMed ID: 26884592
[TBL] [Abstract][Full Text] [Related]
15. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Lutsyk M; Awawda M; Gourevich K; Ben Yosef R
Am J Clin Oncol; 2021 Sep; 44(9):482-486. PubMed ID: 34269693
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
Leong YH; Leong CN; Tay GS; Sim R; Lopes G; Low W; Choo BA; Tey J
Ann Acad Med Singap; 2014 Dec; 43(12):569-75. PubMed ID: 25588915
[TBL] [Abstract][Full Text] [Related]
17. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.
Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1651-60. PubMed ID: 24880919
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study.
Fekete Z; Muntean AS; Hica Ş; Rancea A; Resiga L; Csutak C; Todor N; Nagy VM
J Gastrointestin Liver Dis; 2014 Jun; 23(2):171-8. PubMed ID: 24949609
[TBL] [Abstract][Full Text] [Related]
19. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
Mizushima T; Ikeda M; Kato T; Ikeda A; Nishimura J; Hata T; Matsuda C; Satoh T; Mori M; Doki Y
BMC Cancer; 2019 Sep; 19(1):929. PubMed ID: 31533662
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients.
Osti MF; Agolli L; Bracci S; Masoni L; Valeriani M; Falco T; De Sanctis V; Maurizi Enrici R
Int J Colorectal Dis; 2014 Jul; 29(7):835-42. PubMed ID: 24825722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
